AUTHOR

Dr Matthew Partridge

Matthew graduated from the University of Durham in 2004; he then did an MSc, followed by a PhD at the London School of Economics.

He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.

Matthew is the author of Superinvestors: Lessons from the greatest investors in history

Follow Matthew on Twitter: @DrMatthewPartri

Trading: a cheap broker set to bounce
Trading

Trading: a cheap broker set to bounce

Interdealer broker TP ICAP is cheap, expanding steadily and restoring its dividend. Matthew Partridge explains the best way to play it.
19 Jul 2021
Pandemic plunderers target Daily Mail
UK stockmarkets

Pandemic plunderers target Daily Mail

Share in Daily Mail and General Trust jumped by 10% this week after rumours that the newspaper business would be taken private.
16 Jul 2021
Tate & Lyle takeover proves sweet for private equity
UK stockmarkets

Tate & Lyle takeover proves sweet for private equity

Tate & Lyle has proved an enticing morsel for private-equity group KPS Capital Partners, which is buying part of its operations. Matthew Partridge rep…
16 Jul 2021
Betting on politics: the odds on Keir Starmer leaving
Betting on politics

Betting on politics: the odds on Keir Starmer leaving

Labour's recent by-election win has eased the pressure on Kier Starmer. But there's still plenty of action in the betting markets, as Matthew Partridg…
9 Jul 2021
Unsportsmanlike conduct at JD Group
Retail stocks

Unsportsmanlike conduct at JD Group

JD Group shareholders have staged a revolt over executive pay.
9 Jul 2021
Private equity's supermarket sweep
Retail stocks

Private equity's supermarket sweep

The private-equity battle for Wm Morrison is intensifying now that it has accepted a bid from Fortress Investment. Matthew Partridge reports
9 Jul 2021
Shake-up at GSK won’t placate investors
UK stockmarkets

Shake-up at GSK won’t placate investors

GSK has launched a radical shakeup of its operations, but that's unlikely to satisfy investors unhappy with the drugmaker's perennial underperformance…
2 Jul 2021
Nvidia's Arm Holdings takeover gets vote of support
Tech stocks

Nvidia's Arm Holdings takeover gets vote of support

Three top chipmakers have expressed support for Nvidia's controversial $40bn takeover of Arm Holdings. But it could still fail. Matthew Partridge repo…
2 Jul 2021
Soho House IPO: celebrities’ hangout hits the market
US stockmarkets

Soho House IPO: celebrities’ hangout hits the market

Soho House has filed for an initial public offering in New York that values the group at more than $3bn.
25 Jun 2021
Morrisons takeover bid: supermarket is an attractive target for private-equity buyers
Retail stocks

Morrisons takeover bid: supermarket is an attractive target for private-equity buyers

A private-equity group has made an offer for Morrisons, Britain’s fourth-largest supermarket. Other bids are likely to emerge. Matthew Partridge repor…
25 Jun 2021
Investing in stem cells, the building blocks of the body
Share tips

Investing in stem cells, the building blocks of the body

Stem cells have always been tomorrow’s technology. But it looks as though their time has finally come – and they will transform the treatment of disea…
18 Jun 2021
Betting on politics: who will win Norway's general election?
Betting on politics

Betting on politics: who will win Norway's general election?

Norway is due to go to the polls in a general election in a few months’ time. Matthew Partridge casts his eyes over the candidates and picks a favouri…
18 Jun 2021
How to short AMC shares
Trading

How to short AMC shares

US cinema chain AMC is the latest meme stock and is now absurdly overvalued, says Matthew Partridge, Here's how to play it.
18 Jun 2021
Shell’s fast track to a green-energy future
Stockmarkets

Shell’s fast track to a green-energy future

Shell, the oil major, has had to accelerate plans to go green, and may now ditch highly profitable assets in America. Matthew Partridge reports
17 Jun 2021
Didi Chuxing – “China’s Uber” – arrives for New York stockmarket listed
US stockmarkets

Didi Chuxing – “China’s Uber” – arrives for New York stockmarket listed

Chinese minicab company Didi Chuxing has filed for an initial public offering (IPO) in the US.
17 Jun 2021
Anglo American’s coal spin-off Thungela Resources fails to catch fire
Stockmarkets

Anglo American’s coal spin-off Thungela Resources fails to catch fire

Investors have turned their noses up at Thungela Resources, the London-and-Johannesburg-listed South African coal business spun out of Anglo American
11 Jun 2021
A twist in the tale at struggling cinema chain AMC
US stockmarkets

A twist in the tale at struggling cinema chain AMC

American cinema chain AMC may have secured a new lease of life now that it has become the new GameStop. Matthew Partridge reports.
10 Jun 2021
Why you should short Tesla, the electric-car maker running on empty
Trading

Why you should short Tesla, the electric-car maker running on empty

Electric-vehicle maker Tesla is absurdly pricey and faces stiff competition from rivals, says Matthew Partridge. Here’s how to play it.
9 Jun 2021
Curtain up at Cineworld as lockdown ends, but threats remain
UK stockmarkets

Curtain up at Cineworld as lockdown ends, but threats remain

Cineworld’s shares rose as people returned to cinemas in their droves. But streaming companies such as Netflix and Amazon aren’t standing still. Matth…
28 May 2021
Credit Suisse’s bankers’ exodus endures
Stockmarkets

Credit Suisse’s bankers’ exodus endures

Senior bankers continue to leave Credit Suisse, after the bank cut the amount of money set aside for employee bonuses.
27 May 2021
How to invest in the fight against Alzheimer’s disease
Biotech stocks

How to invest in the fight against Alzheimer’s disease

The cost of caring for those with dementia is a growing problem for healthcare systems around the world. Any firm that develops an effective treatment…
21 May 2021
A show of support for GlaxoSmithKline's hedge fund fight
Biotech stocks

A show of support for GlaxoSmithKline's hedge fund fight

Several large shareholders have said that they will support GlaxoSmithKline in its battle with hedge fund Elliott Management.
21 May 2021
AT&T ditches media dreams as it spins out WarnerMedia
US stockmarkets

AT&T ditches media dreams as it spins out WarnerMedia

Communications group AT&T is spinning off its WarnerMedia business just three years after buying it. Matthew Partridge reports
20 May 2021
Vaccine patents: a bitter pill for drug companies
Biotech stocks

Vaccine patents: a bitter pill for drug companies

The US has suggested waiving drug companies’ vaccine patents to hasten the defeat of Covid-19, sending their share prices down.
14 May 2021
AstraZeneca’s shareholders rebel over pay
Biotech stocks

AstraZeneca’s shareholders rebel over pay

Shareholders in AstraZeneca have rebelled over proposals to raise bonus levels for its bosses.
14 May 2021
BP: really going “beyond petroleum” won't be easy
Energy stocks

BP: really going “beyond petroleum” won't be easy

BP is recovering and plans to become carbon neutral by 2050. Meanwhile, activist investors are targeting ExxonMobil. Matthew Partridge reports
30 Apr 2021
Tate & Lyle to offload its sweeteners division
UK stockmarkets

Tate & Lyle to offload its sweeteners division

Former sugar producer Tate & Lyle is exploring the sale of the part of the firm that produces sweeteners, to focus on its fast-growing food and bevera…
29 Apr 2021
Spreadbetter Plus500 will add to profits – here's how to play it
Trading

Spreadbetter Plus500 will add to profits – here's how to play it

Plus500, the financial trading platform, surged in lockdown but will also ride the recovery, says Matthew Partridge.
26 Apr 2021
How to invest as the aviation sector bounces back from Covid-19
Share tips

How to invest as the aviation sector bounces back from Covid-19

Shares in airlines have soared over the past few weeks as hopes of a return to normality have risen. Do they have further to climb? And which will do …
23 Apr 2021
Arm Holdings takeover: has Nvidia had its chips?
Tech stocks

Arm Holdings takeover: has Nvidia had its chips?

The takeover of Britain’s semiconductor group Arm Holdings by its US rival Nvidia could be running into the sand, says Matthew Partridge.
22 Apr 2021
Activist investor Elliott takes takes a stake in Glaxo
Biotech stocks

Activist investor Elliott takes takes a stake in Glaxo

Elliott, s US hedge fund, took an undisclosed multibillion-pound stake in GSK last week, driving the share price up by 4.6%.
22 Apr 2021
Alibaba’s legal woes look far from over
China stockmarkets

Alibaba’s legal woes look far from over

China’s top e-commerce firm Alibaba was hit with a $2.75bn fine for antitrust violations. But this may not be the end of the matter, with regulators e…
16 Apr 2021
Clouds gather over Darktrace’s £3bn stock-exchange listing
UK stockmarkets

Clouds gather over Darktrace’s £3bn stock-exchange listing

Darktrace, the cybersecurity star, is planning to list on the London Stock Exchange. It is a promising company, but its top shareholder is in legal tr…
16 Apr 2021
World's biggest fraudster Bernie Madoff has died – what was his scam?
Investment strategy

World's biggest fraudster Bernie Madoff has died – what was his scam?

Bernie Madoff, perpetrator of the world's biggest Ponzi scheme, has died in prison at the age of 82. Matthew Partridge looks at his massive fraud sche…
14 Apr 2021
The bitcoin bubble will burst: here’s how to play it
Bitcoin

The bitcoin bubble will burst: here’s how to play it

The cryptocurrency’s price has soared far beyond its fundamentals, says Matthew Partridge. Here, he looks at how to short bitcoin.
12 Apr 2021
Why LG stopped making smartphones
Tech stocks

Why LG stopped making smartphones

LG, the Korean electronics group, was one of the smartphone market’s first movers. Now it has joined a group of has-beens, such as Nokia. Matthew Part…
8 Apr 2021